Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Solid Tumors × fludarabine × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 3 Leukemia 3 Burkitt Lymphoma 3 Solid Tumors 1 Solid Tumor 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Hematologic Neoplasms 1 Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited 1

Interventions

fludarabine 1 Interleukin-2 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05648994 2022-12-13

TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors

Fujian Cancer Hospital

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡